Salabè G B
CNR Institute of Neurobiology and Molecular Medicine, Rome, Italy.
Biomed Pharmacother. 2001 Feb;55(1):39-53. doi: 10.1016/s0753-3322(00)00010-x.
Thyroid nodule genesis may be considered as an amplification of thyroid heterogeneity due to genetic and/or epigenetic mechanisms. We classified the thyroid nodules in five types with distinct histological features: hyperplastic, neoplastic, colloid, cystic and thyroiditic nodules. Hyperplastic: Thyrocyte proliferation is under the control of TSH but several other paracrine and autocrine factors are secreted by follicular cells, the stromal apparatus and the lymphocytes, which are implicated in initiation and perpetuation of thyroid hyperplasia. Growth occurs mainly through TSHR, cAMP and PKA. Constitutive cAMP overproduction has been shown to be due to point mutation of the TSHR or Gs protein, producing overgrowth and hyperfunction. Neoplastic: Several activated oncogenes have been identified in thyroid malignancies. Oncogenes relevant to the thyroid carcinogenesis are: mutated TSHR and gsp (constitutive activation of cAMP); TRK (receptor for NGF); RET/PTC (phosphorylation of tyrosine kinase receptor)--an isoform of this oncogene is induced by radiation: ras (it encodes Gs proteins transducing mitogenic signals); and c-MET (receptor for hepatocyte growth factor). The evolution of a differentiated thyroid cancer towards an undifferentiated cancer is due to a mutation of a family of proteins (i.e., p53), which acts as a brake, preventing the genomic instability of cancer. It is suggested that a tumor initiates by RET or ras and possibly progresses--as a result of additional mutations and by p53 mutation--to anaplastic carcinoma. Colloid: Flattening of the epithelium and dilatation of follicles containing viscous material--made up by a concentrated solution of thyroglobulin (hTg)--is the characteristic of the colloid nodule. A defect of intraluminal reabsorption of hTg has been suggested but not proven. Experimentally, a load of iodine is able to change thyroid hyperplasia to a colloid feature; however, a load of iodine is rarely found in the clinical history of patients. A new clue to the pathogenesis comes from the finding that a relevant part of the colloid (10-20%) is made up of insoluble globules, where hTg is compacted in a polymeric form. It is suggested that stocking hTg into globules is defective in colloid nodules, leading to enormous enlargement of the follicle. Cystic: It is estimated that between 15 and 40% of thyroid nodules are partly or entirely cystic. The 'true cyst' is rare; most of the so-called cystic nodules are 'pseudocysts', which follow necrosis and colliquation. Necrosis issues as an imbalance between growth and the precisely regulated process of angiogenesis. More recently, the VEGF/VPF has been found to be at the origin of recent and recurrent cysts. Immunotoxic and apoptotic mechanisms have also been suggested. Chemical analysis of cystic fluid showed a 'denatured' and 'serum-like' pattern suggesting different mechanisms in the pathogenesis of the pseudocystic thyroid nodules. Thyroiditic: Nodular lymphocytic thyroiditis (NLT) includes two different entities: 1) lymphocyte thyroiditis growing as a nodule in a hyperplastic or normal gland, and 2) lymphocyte thyroiditis associated in the same nodule with other nodular diseases of the thyroid: papillary thyroid carcinoma and lymphoma have been found to be associated to chronic lymphocytic thyroiditis.
甲状腺结节的发生可被视为由于遗传和/或表观遗传机制导致的甲状腺异质性放大。我们将甲状腺结节分为具有不同组织学特征的五种类型:增生性、肿瘤性、胶样、囊性和甲状腺炎性结节。增生性:甲状腺细胞增殖受促甲状腺激素(TSH)控制,但滤泡细胞、间质结构和淋巴细胞会分泌其他几种旁分泌和自分泌因子,这些因子与甲状腺增生的起始和持续有关。生长主要通过促甲状腺激素受体(TSHR)、环磷酸腺苷(cAMP)和蛋白激酶A(PKA)发生。已证明组成性cAMP过度产生是由于TSHR或Gs蛋白的点突变,导致过度生长和功能亢进。肿瘤性:在甲状腺恶性肿瘤中已鉴定出几种激活的癌基因。与甲状腺癌发生相关的癌基因有:突变的TSHR和gsp(cAMP的组成性激活);TRK(神经生长因子(NGF)受体);RET/PTC(酪氨酸激酶受体磷酸化)——这种癌基因的一种异构体由辐射诱导;ras(它编码转导促有丝分裂信号的Gs蛋白);以及c-MET(肝细胞生长因子受体)。分化型甲状腺癌向未分化癌的演变是由于一类蛋白质(如p53)的突变,该蛋白质起到制动作用,防止癌症的基因组不稳定。有人认为肿瘤由RET或ras引发,并可能由于额外的突变以及p53突变而进展为未分化癌。胶样:上皮细胞扁平以及含有由甲状腺球蛋白(hTg)浓缩溶液组成的粘性物质的滤泡扩张是胶样结节的特征。有人提出但未证实hTg腔内重吸收存在缺陷。实验表明,碘负荷能够将甲状腺增生转变为胶样特征;然而,在患者的临床病史中很少发现碘负荷。发病机制的一个新线索来自于这样的发现,即胶样的一个相关部分(10 - 20%)由不溶性小球组成,其中hTg以聚合形式紧密堆积。有人认为在胶样结节中hTg储存到小球存在缺陷,导致滤泡巨大扩张。囊性:据估计,15%至40%的甲状腺结节部分或完全为囊性。“真性囊肿”罕见;大多数所谓的囊性结节是“假性囊肿”,是坏死和液化的结果。坏死是生长与精确调节的血管生成过程之间失衡的结果。最近,已发现血管内皮生长因子/血管通透因子(VEGF/VPF)是近期和复发性囊肿的起源。也有人提出了免疫毒性和凋亡机制。囊液的化学分析显示出“变性”和“血清样”模式,提示假性囊性甲状腺结节发病机制中的不同机制。甲状腺炎性:结节性淋巴细胞性甲状腺炎(NLT)包括两种不同的实体:1)在增生性或正常腺体中以结节形式生长的淋巴细胞性甲状腺炎,以及2)在同一结节中与甲状腺其他结节性疾病相关的淋巴细胞性甲状腺炎:已发现乳头状甲状腺癌和淋巴瘤与慢性淋巴细胞性甲状腺炎相关。